Bone Marrow Transplant Research
Until we cure everybody with cancer, oncology in an academic setting must be research driven. The Bone Marrow Transplant Program Research Team is comprised of a wide variety of clinical research professionals including scientists, research nurses, data managers and biostatisticians that provide our medical professionals with a depth of experience, expertise and leadership in the field. The Bone Marrow Transplant program offers state-of-the art therapies for autologous, allogeneic and non-myeloablative allogeneic bone marrow transplants as treatment for cancer.
Each year, we embark on newly sponsored bone marrow transplant research protocols, cooperative group studies, as well as our own authored protocols. We conduct cutting edge clinical research in a myriad of aspects of bone marrow transplants. We have a special interest in studies designed to reduce bone marrow transplant related toxicities and studies that investigate improved methods for collecting peripheral stem cells prior to an autologous transplant. Additionally, we have become one of the two leading bone marrow transplant centers with vibrant clinical research dedication to psychosocial aspects of our patients.
We take our bone marrow transplant research projects to fruition and present the results at national meetings, and publish them in peer-reviewed journals. The year 2005 was a pinnacle, record-breaking year for the number of abstracts submitted to the American Society of Hematology Annual Meeting, the pre-eminent scientific meeting for bone marrow transplants. At this meeting, investigators in our Program will be presenting valuable data to researchers and clinicians from all over the world, in regards to bone marrow transplants.
To further our bone marrow transplants research productivity, we are actively involved in the Center for International Bone Marrow Transplant Research. The CIBMTR collects a vast amount of data concerning bone marrow transplantation, which is used to guide clinical decisions and improve bone marrow transplant outcomes.
Our Bone Marrow Transplant Program is recognized as a leader in the field of bone marrow transplant and patients are referred to us because we offer many opportunities for a patient to benefit from a bone marrow transplant clinical trial. Our objective is to have research trials available for a variety of clinical situations, which meet the needs of our patients. We are exceedingly committed to improve upon transplant toxicities and patient outcomes. To this end, we open new research trials every year that are designed to explore new bone marrow transplant treatment options and investigate innovative therapies. We have a large team of dedicated bone marrow transplant research personnel to help accomplish these goals.
Cancer Answers & Appointments
Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.
Monday through Friday from 8 a.m. – 4:30 p.m. (ET).
Resources for medical professionals
- Outpatient appointment referrals: 216.444.7923 or 866.223.8100
- Inpatient hospital transfers: 800.553.5056
- Referring Physician Concierge: 216.444.6196 or 216.312.4910.
Search available cancer clinical trials by disease, hospital, phase or number.
This information is provided by Cleveland Clinic and is not intended to replace
the medical advice of your doctor or health care provider.
Please consult your health care provider for advice about a specific medical condition.
© Copyright 2015 Cleveland Clinic. All rights reserved.